near term outlook bit wors expect plenti offset posit
report result miss bogey top-lin due
beat ep importantli compani trend toward top-lin growth
quarter viru hurt volum better-than-expect
success counter aha data us indic surgeon examin
impella independ determin devic util certainli worth
perceiv risk clear posit updat manag commentari impact
viru volum near-term bit wors expect
believ investor larg look med-tech
point compani product pipelin remain rich addit ecmo system
oxygen introduct key opinion expand sheath still
track later year earli
result revenu essenti flat yoy miss target
would beaten impact
favor disclosur view anticip compani might risk
miss sale estim pre-covid given headwind aha data gross
margin miss bogey bp tight cost control led adjust ep
beat target coupl penni round model may
cost us penni ep
guidanc provid like much med tech moment given uncertainti
around viru outbreak provid fiscal guidanc
make signific cut revenu oper incom estim result
manag gener commentari call
takeaway call outlook busi fiscal
bit weaker might expect given type patient treat
fiscal result trend ahead expect hit
particularli import investor anticip busi would soft follow
public aha data clearli case compani would
deliv revenu growth medic educ provid
clinician clearli work continu believ compani signific growth
ahead come year end manag indic continu
develop view robust product pipelin importantli expand
sheath reduc vascular complic track fiscal
submiss roll-out late fiscal year like fiscal continu
develop manufactur circulatori support devic
ev/ci sale
debt total capit
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
takeaway call cont continu one best portfolio
product includ ecmo technolog purchas yesterday improv oxygen
certain patient med tech believ lead acceler revenu
growth come year view
stock thought bit surpris see share much open today
magnitud fiscal cut bit higher anticip howev rebound
busi fiscal certainli unexpect surpris clearli investor look
near term impact franchis still monopoli provid highli
differenti technolog excel balanc sheet construct view compani
remain rate share abiom ow price target move unchang
page
good gener incom expens net incom net incom analysi gross gener analysisu impella impella
thousand except per share data
good sold
good sold
percent sale
good sold
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
